United States · Seed startup

Who invested in Natalist

One round we have observed, with the 11 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$5.0Mraised across 1 round since 2019, from 1 source

Latest round
Seed, $5.0MOct 2019
Led by
Cowboy Ventures
Investors
11 (1 led)
See who backed them

The rounds

  1. Oct 2019
    Seed$5.0M

    Reported by FinSMEs

Everyone who backed them

Cowboy VenturesVC firm1round, led 1
Collaborative FundVC firm1round
Rock HealthVC firm1round
Fuel CapitalVC firm1round
John DoerrVC firm1round
XfundVC firm1round
Malay GandhiAngel1round
Christine Lemkeno record of our own yet1round
David Viverono record of our own yet1round
Julia Cheekno record of our own yet1round
R. Martin Chavezno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Natalist

Who invested in Natalist?

Natalist's investors include Cowboy Ventures, Collaborative Fund, Rock Health, Fuel Capital and John Doerr, and 6 more on record. Cowboy Ventures led its latest round.

How much has Natalist raised?

Natalist has raised $5.0M across 1 round since 2019.

When did Natalist last raise?

Natalist's most recent round was a Seed of $5.0M in Oct 2019, led by Cowboy Ventures.

What was Natalist's biggest round?

Its most recent round, $5.0M in Oct 2019, is also its largest on record.

Who backed Natalist first?

Natalist's first round on record, in Oct 2019, was backed by Cowboy Ventures, Collaborative Fund and Rock Health and 8 others.

What stage is Natalist at?

Natalist's latest named round is a Seed, in Oct 2019.

Where is Natalist based?

Natalist is based in the United States.

Who led Natalist's rounds?

Cowboy Ventures led the Seed in 2019.

Companies like Natalist

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.